← All Jobs
Posted Apr 11, 2026

Business Development Manager, Immunoassays & Biomarkers (MidAtlantic)

Apply Now

Spear Bio, founded in 2021, is a well-funded and rapidly growing biotech start-up headquartered in Woburn, Massachusetts.  Our proprietary technology, Successive Proximity Extension Amplification Reaction (SPEAR), is a novel wash-free immunoassay platform, offering unprecedented sensitivity. We are dedicated to revolutionizing early disease diagnosis and monitoring by providing scalable, ultrasensitive solutions that deliver unparalleled accuracy in measuring low-abundant biomarkers, enabling clinicians and researchers to improve patient outcomes and advance global health.

Position Summary:

Spear Bio is seeking top-performing Business Development Managers to introduce our high-performance and expanding portfolio of ultra-sensitive Immunoassays to the Life Sciences and CRO markets. We are hiring individuals based in the MidAtlantic (Philadelphia, DC, Maryland, Virginia) with a deep network of neurodegenerative disease research customers in Big Pharma, Biotech, CROs, & Academic throughout the MidAtlantic region.

Key Responsibilities:

Required Qualifications:

We offer competitive compensation, meaningful stock ownership, comprehensive benefits, and a great work environment. This is an opportunity to enter an innovative, high-growth startup at an early stage and play an integral role in the company's growth and success. We are focused on identifying candidates who have demonstrated leadership and excellence throughout their careers and are excited by the prospect of building an industry-leading company.

Spear Bio Inc. provides equal opportunity in employment to all persons. No person shall be denied equal access because of race, creed, color, religion, national origin, sex, sexual orientation, gender identity, age, or physical/mental disability.

Spear Bio does not accept resume submissions from external recruiting agencies. Any unsolicited resumes or candidate information submitted without prior written agreement will be deemed the property of Spear Bio, and no placement fees will be paid.